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Abstract
Background: Environmental disinfection with continuously antimicrobial surfaces could offer superior control of
surface bioburden. We sought to decide the efficacy of photocatalyst antimicrobial coating in reducing methicillin-
resistant Staphylococcus aureus (MRSA) acquisition in high incidence setting.
Methods: We performed prospective cohort study involving patients hospitalized in medical intensive care unit. A
titanium dioxide-based photocatalyst was coated on high touch surfaces and walls. Five months of pre-intervention
data were compared with five months of post-intervention data. The incidence rates of multidrug-resistant organism
acquisition and the rates of hospital-acquired blood stream infection, pneumonia, urinary tract infection, and Clostridium
difficile–associated diseases were compared using Cox proportional hazards regression analysis.
Results: In total, 621 patients were included. There was significant decrease in MRSA acquisition rate after photocatalyst
coating (hazard ratio, 0.37; 95% confidence interval, 0.14–0.99; p = 0.04). However, clinical identification of vancomycin-
resistant Enterococcus spp. and multidrug-resistant Acinetobacter baumannii did not decrease significantly. The hazard of
contracting hospital-acquired pneumonia during the intervention period compared to baseline period was 0.46
(95% confidence interval, 0.23–0.94; p = 0.03).
Conclusions: In conclusion, MRSA rate was significantly reduced after photocatalyst coating. We provide evidence
that photocatalyst disinfection can be an adjunctive measure to control MRSA acquisition in high-incidence settings.
Trial registration: ISRCTN Registry (ISRCTN31972004). Registered retrospectively on November 19, 2018.
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Background
Multidrug-resistant organisms (MDROs), including
methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant Enterococcus spp.(VRE), and
multidrug-resistant Acinetobacter baumannii (MRAB),
have increased in prevalence in many acute and long-term
care facilities [1]. Controlling hospital-acquired infections
(HAIs) associated with these organisms has become a
major challenge [2, 3].
As patient-to-patient spread is a major route of MDRO
transmission, hand hygiene and isolation are pivotal infec-
tion control measures [4]. However, compliance with these
measures is low [5]. Hospital environments could be source
of outbreaks of resistant organisms [6], and experts suggest
indirect transmission via the environment to be as likely as
direct person-to-person transmission [7]. Although The So-
ciety for Healthcare Epidemiology of America recommends
environmental cleaning only with moderate strength [4],
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enhanced environmental cleaning can reduce MDRO
transmission [7–9].
Several technologies have proven antibacterial efficacy
and these include hydrogen peroxide vapor [10–14], ultra-
violet (UV) light decontamination [15, 16], and copper-
and silver-coated surfaces [17–19]. However, their use is
limited by high cost or high risk of recontamination.
Among currently recognized alternatives are photo-
catalytic antimicrobial coating. Photocatalysis mainly
uses a semiconductor such as titanium dioxide (TiO2)
that can absorb UV wavelength < 400 nm and stimulate
reactions on its surface producing highly reactive oxygen
species (ROS), contributing to biocidal activity. Pres-
ently, further improvements such as composite TiO2
have enabled activation under visible light, increasing
availability in hospital settings [20]. Since this material is
stable with respect to self-destruction and responsive-
ness to light, it is presumed to have durable antimicro-
bial activity [21]. Furthermore, TiO2 has better safety
data than pure copper- and silver-coated surfaces, espe-
cially when exposed in low doses, such as in environ-
mental coating [22–24].
Although many in vitro studies have presented positive
results of photocatalytic antimicrobial action with tita-
nia, only little work in real life application has been re-
ported. These works raise numerous issues about
applying this material in hospital environment. Inappro-
priately incorporated binder, which acts as a glue to ad-
here TiO2 to the surface, could prevent the action of
photocatalyst [25]. Even if properly manufactured, slow
action time of photocatalyst makes it act as a supple-
mental measure to the conventional decontamination
procedures at best [26]. Furthermore, others argue that
its effect is not significant on already thoroughly cleaned
surfaces [27].
Recognizing the significance of these issues, we de-
cided to use metal ion-doped nanoparticle TiO2, which
is firmly attached to the surface, as adjunctive measure
of environmental decontamination. Additionally, we rec-
ognized high incidence rates of MRSA at this institute
(3-year average incidence from 2014 to 2016 was 7.7/
1000 patient-days). Taken together, we sought to evalu-
ate the usefulness of a photocatalyst to reduce the risk
of MRSA transmission, by comparing MRSA acquisition
rate and nosocomial infection rate before and after
photocatalyst coating.
Methods
Setting
The study was performed at a 630-bed secondary care
teaching hospital in Gyeonggi-do, South Korea. This insti-
tution has two adult intensive care units (ICUs), medical
and surgical, with 14 and 15 beds each, and has an average
of 600–650 admissions annually. Medical ICU is a single
room, composed of three sections that are interconnected.
We only included the medical ICU in this study.
Study design
We performed a prospective cohort study involving pa-
tients hospitalized in the medical ICU between September
2016 and June 2017. The study was divided into 5-month
baseline and post-intervention periods: baseline period,
September 2016 to January 2017; intervention period, Feb-
ruary 2017 to June 2017. Photocatalyst was uniformly
coated on high tough surfaces and walls at the end of
January 2017. All patients admitted to the medical ICU
during the study period were included with the exception
of patients aged < 18 years and patients hospitalized less
than 72 h. Only first episode of ICU admission was in-
cluded in the analysis, with the exception of a second epi-
sode that was ≥3months from the previous episode.
Routine infection control procedures were maintained
throughout the study period, including hand hygiene
monitored by infection control nurses (142 to 176 obser-
vations per month), isolation of patients with known
transmissible disease, and conforming to ICU bundle
recommended by The Centers for Disease Control and
Prevention guidelines [28].
Surface areas, including patient body surfaces, were
cleaned throughout the study period. All ICU patients
were washed with chlorhexidine-impregnated cloth
every 3 days. High-touch surfaces such as upper and
lower benches, computer keyboards and mouse, tele-
phones in the nursing station, and mobile equipment
such as blood pressure monitoring machines, items in
blood collection trolleys, and bed rails were cleaned with
chlorhexidine-impregnated cloth. Floors of the rooms of
non-isolated patients were cleaned daily with neutral de-
tergent, while sodium hypochlorite (1000 ppm) was used
for cleaning areas with known VRE, Clostridium-diffi-
cile–associated disease (CDAD) patients. At this insti-
tute, annual general deep cleaning of ICU, which
comprises thorough cleaning with neutral detergent
followed by waxing after moving patients to other wards,
had been taking place, usually at the end of the year or
in January of the next year.
The primary outcome of the study was incident MRSA
acquisition rate. Nursing staff obtained swabs from pa-
tients’ nares up to 48 h after ICU admission and on dis-
charge from ICU. A new MRSA acquisition was defined
as a patient not positive for MRSA on admission who
subsequently became positive following screening cul-
ture after admission. The term “acquisition” was consid-
ered synonymous with “colonization” or “infection”
obtained after negative culture on ICU admission. The
nasal swabs were plated onto chromogenic media (bio-
Mérieux, Marcy l’Etoile, France) for S. aureus detection.
Subsequently, S. aureus was subcultured on Mueller–
Kim et al. BMC Infectious Diseases          (2018) 18:610 Page 2 of 9
Hinton Agar plus cefoxitin for investigating cefoxitin
resistance.
Secondary outcome measures included VRE and
MRAB isolates from clinical sites, CDAD and HAIs
(bloodstream infection, pneumonia, and urinary tract in-
fection) as defined by The Centers for Disease Control
and Prevention [29]. Microorganisms and their antibiotic
sensitivities were identified using Vitek2 (bioMérieux,
Marcy l’Etoile, France). MRAB was defined as resistance
to more than three classes of antibiotics. CDAD was di-
agnosed by real-time polymerase chain reaction for C.
difficile toxin A and B gene or by stool culture for pa-
tients having diarrhea.
Specimens for environmental surveillance cultures were
collected by infection control nurses to assess extent of
contamination or disinfection. Thirty high-touch surfaces
including bedside rails, tabletops, nursing trolley tops,
door handles, tap handles, and computer keyboards and
mouse were sampled. Surveillance cultures were per-
formed bimonthly, 3 times each during the baseline and
post-intervention periods. Polywipe sponge swabs (Med-
ical Wire & Equipment, Corsham, UK) were used, and im-
bedded in thioglycollate medium (Becton Dickinson, SA,
France) and cultured for detection of microorganisms.
The results were shown as percentage of positive bacterial
cultures against entire cultures performed.
Intervention
We used a nanoparticle TiO2 doped with transition
metal ion (iron included), which can respond to visible
light (NexChem, Chungcheongbuk-do, South Korea).
The area was vacated for 24 h after which the photocata-
lyst was applied and dried. The unit was thoroughly
cleansed before photocatalyst application. An electro-
static spray was used to generate atomized droplets that
were deposited uniformly on various surfaces. It was
then dried to form a tough, adherent monolithic film on
the coated surface. All plastic and metal surfaces such as
upper and lower benches, bedside rails, tabletops, nurs-
ing trolley tops, door handles, tap handles, telephones in
the nursing station, blood pressure monitoring machines
and walls were sprayed. The procedure commenced on
January 26, 2017, and ended on January 27, 2017.
Data collection
We collected baseline clinical data, including patient age
and sex, length of ICU stay, length of hospital stay,
pre-existing chronic comorbidities (diabetes, chronic
heart failure, chronic liver disease, chronic renal disease,
chronic pulmonary disease), sequential organ failure as-
sessment score, admission history within 3months prior
to ICU admission, previous invasive procedure (central
line insertion, intubation, continuous renal replacement
therapy, surgery under general anesthesia), and length of
antibiotics treatment.
Hospital-acquired pneumonia, BSI, and UTI were de-
fined based on The Centers for Disease Control and Pre-
vention criteria. The absolute numbers of infection cases
was divided by total patient-days and described as
events/1000 patient-days.
Statistical analysis
Patients who stayed across baseline and post-intervention
periods in the ICU were excluded from analysis. Baseline
characteristics were compared using Mann–Whitney U
test or independent samples t-test for continuous vari-
ables, and χ2 test or Fisher’s exact test for categorical vari-
ables. Continuous variables were expressed as means, or
medians (interquartile ranges) and categorical variables as
numbers with percentages for the description of baseline
characteristics.
The intervention effect was measured in terms of haz-
ard and incidence rate ratios. The relative hazard of
MDROs acquisition was calculated using a Cox propor-
tional hazards model, adjusted for clinically relevant
confounders in addition to variables that showed statis-
tical differences in univariate analysis. The proportional
hazards assumption was tested by including an inter-
action term between variables. We excluded variables
that did not fit the assumption of proportionality. Pa-
tients were categorized into two groups as baseline and
intervention period. Survival curves were created using
the Kaplan–Meier method and compared using the
log-rank test. Variables were considered significant at p
< 0.05, and the results were presented as hazard ratios
with 95% confidence intervals (CIs). Subgroup analysis
stratified by length of ICU stay was conducted to iden-
tify either consistency of or differences in the magnitude
of intervention effect.
Statistical analyses were performed using R software
version 3.4.2 (R Development Core Team 2016; http://
www.r-project.org/).
Results
Patient characteristics
In total, 858 patients were admitted to the ICU during
the study period. Among them, 233 were excluded due
to young age or short length of hospital stay and 4 due
to staying across baseline and post-intervention periods.
Finally, 341 and 280 patients during baseline and inter-
vention periods, respectively, were enrolled. Therefore,
data from 621 patients were analyzed. Mean age of en-
rolled patients was 67.56 years and 59.5% were men.
Mean length of ICU stay was 4.87 days: baseline period,
4.30 days; intervention period, 5.40 days. Mean length of
hospital stay was 23.50 days: baseline period, 21.07 days;
intervention period, 26.46 days. Overall mortality was
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13.7%. There was no significant difference in underlying
diseases between the groups except for number of
patients having chronic renal disease, which was slightly
higher in the intervention group (18.1% vs. 25.5%, p = 0.03).
Previous admission history, length of antibiotics treatment,
admission route, and sequential organ failure assessment
score were not statistically different. Invasive procedures
were conducted equally in both groups. The proportion of
MRSA colonizers who acquired MRSA before ICU admis-
sion was same between the groups (Table 1). The compli-
ance of hand hygiene of physicians remained low across
study periods (Fig. 1).
Acquisition of MRSA
During baseline period, 15 newly acquired MRSA cases
were detected compared with 4 during the intervention
period. Incidence rate reduced from 9.3/1000 patient-days
before intervention to 2.57/1000 patient-days after inter-
vention. Cox proportional hazards survival regression ana-
lysis showed the risk of acquiring MRSA was significantly
lower in the intervention period than in the baseline
period (p = 0.03) (Fig. 2). After adjusting for sequential
organ failure assessment score, renal function, and length
of ICU stay, the hazard of acquiring MRSA during the
intervention vs. baseline period was 0.37 (95% CI, 0.14–
0.99; p = 0.04). This effect was greater among patients with
longer length of stay. Among patients who stayed longer
than 7 days in ICU, the relative hazard was 0.26 (95% CI,
0.07–0.96; p = 0.04). Figure 2 shows MRSA acquisition
rates stratified by date of admission between baseline and
intervention periods. MRSA acquisition rate was signifi-
cantly reduced after photocatalyst application and
remained low throughout the intervention period.
The clinical identification of VRE remained low across
study periods and had not been significantly reduced after
intervention (0.62 vs. 1.28/1000 patient-days, p = 0.54). In-
cidence rate of MRAB also did not decrease significantly
(3.09 vs. 3.20/1000 patient-days, p = 0.76) (Table 2).
HAI rate
There was significant reduction in incidence rate of
hospital-acquired pneumonia (baseline vs. intervention
period: 16.12/1000 vs. 7.70/1000 patient-days; p = 0.03).
The hazard of acquiring pneumonia during the interven-
tion vs. baseline period was 0.47 (95% CI, 0.23–0.94; p =
0.03). Pathogens were identified in 76.3% of cases. The
most common pathogen was Gram-negative bacilli (n = 22,
57.9%). MRSA was isolated in 13.16% (n = 5) of cases.
However, no statistically significant reduction in BSI, UTI,
or CDAD was observed. The incidence of BSI was 3.71/
1000 vs. 6.41/1000 patient-days in baseline and interven-
tion periods (p = 0.28). Incidence rate of UTI was 5.58/
1000 vs. 3.21/1000 patient-days in baseline and interven-
tion periods (p = 0.32). The incidence rate of CDAD was
1.23/1000 vs. 0.64/1000 patient-days in baseline and inter-
vention periods (p = 0.52) (Table 2).
Environmental disinfection
Statistically significant decrease of microorganisms on
high-touch surfaces was observed (27/90 [30%] vs. 10/90
[11%], baseline and intervention period respectively;
p = 0.01). Immediately after the intervention, signifi-
cantly lower number of microorganisms was isolated
from the surfaces. Thereafter, lower levels of organ-
isms in the intervention period than in the baseline
period were cultured from the surfaces; however, it
was not statistically significant. The most common
organism isolated was coagulase-negative Staphylococcus
spp. (n = 33, 89.2%). The rest were Bacillus spp. Details of
environmental culture results are provided in supplemen-
tal table (see Additional file 1: Table S1).
Discussion
Photocatalysts are investigative materials for its efficacy
in controlling MDRO in hospital environments. Our
study suggests that photocatalysts are effective in con-
trolling MRSA acquisition. However, it has limited effi-
cacy on MRAB. Proper evaluation of its effect on VRE
was not possible due to paucity of newly acquired cases.
In Asia Pacific region, MRSA remains a threat, ac-
counting for > 50% of S. aureus infections, and MRSA
BSI was reported to be 14.4/10,000 patient-days in 2017
[30]. In such high-prevalence settings, there has been
growing interest in the horizontal approach, such as
chlorhexidine bathing, hand hygiene, and environmental
cleaning instead of isolation. Among these, hand hygiene
itself could be cost-effective way of prevention; however,
it is often difficult to sustain, especially when monitoring
staff is scarce and turnover rate of housekeeping staff is
high. One of the reasons for high MRSA prevalence at
this institute could be that hand hygiene was practiced
at moderate to below average level. Only after temporary
closure of wards had been instituted and full decontam-
ination of the departments using photocatalyst was per-
formed did the MRSA acquisition rate reduce.
Stiefel et al. suggested that healthcare workers’ hands
were equally contaminated from contact with commonly
touched environmental surfaces as from direct contact
with colonized patients [31]. Moreover, MRSA can exist
on surfaces for as long as 360 days [32, 33], increasing
its probability to be transmitted. Our result is promising
in that photocatalyst enhanced the effect in combination
with regular infection control practices that resulted in
lower MRSA acquisition. This result is consistent with
previous in vitro evidence, which was conducted in
aqueous solution demonstrating positive antimicrobial
effect of iron-doped TiO2 on S. aureus [34].
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It is meaningful to note that MRSA acquisition rate
remained low throughout intervention period. Although
pure TiO2 is considered indefinitely active, very few
real-time studies concerning durability of TiO2 coating
have been reported. Instead, laboratory-stimulated en-
durance test is performed as a substitute for real-time
study [35]. The TiO2 coating we used was checked for
its durability with weather-O-meter test (Testing system
for weathering performances CI5000, ATLAS). Never-
theless, existing real-time studies of composite TiO2
coating provide positive results in terms of durability.
Silver-doped TiO2 produced in Japan under the name of
MVX reported to remain active after 2 years of lab test,
according to data provided by the manufacturer [27].
Furthermore, decontamination with zinc containing
TiO2 in a long-term care facility reduced HAIs even
after 17 months [36]. Their result was consistent with
our result on MRSA. The effect was greater among pa-
tients who stayed longer than 7 days in ICU. It is pos-
sible that 72% reduction of MRSA acquisition was
attributed to this durable antimicrobial activity of photo-
catalyst. Notwithstanding other environmental cleaning
Table 1 Baseline characteristics of the study population
Variables Total Baseline Intervention p-value
Patients, n 621 341 280 NA
Male gender, n (%) 370 (59.5) 199 (58.4) 171 (61.1) 0.55
Age (years) 67.56 67.13 68.08 0.43
Total patient days at risk 3171 1613 1558 0.24
Mean length of hospital stay 23.50 21.07 26.46 0.12
Mean length of ICU stay 4.87 4.30 5.40 0.11
Overall mortality, n (%) 85 (13.7) 48 (14.0) 37 (13.7) 0.91
Previous admission Hx. within 3 months, n (%) 139 (22.4) 66 (19.4) 73 (26.1) 0.06
Comorbidities
Cardiovascular disease, n (%) 453 (72.9) 247 (72.2) 212 (75.2) 0.41
Diabetes, n (%) 195 (31.4) 111 (32.5) 84 (29.8) 0.49
Cerebro vascular accident, n (%) 264 (42.5) 146 (42.7) 118 (42.0) 0.87
Solid organ malignancy, n (%) 75 (12.1) 43 (12.6) 32 (11.3) 0.71
Hemaologic malignancy, n (%) 4 (0.6) 3(0.9) 1 (0.4) 0.63
Trauma Hx., n (%) 20 (3.2) 14 (4.1) 6 (2.1) 0.18
Chronic renal disease, n (%) 133 (21.4) 61 (18.1) 72 (25.5) 0.03
Chronic liver disease, n (%) 70 (11.3) 36 (10.5) 34 (12.1) 0.61
Chronic lung disease, n (%) 82 (13.2) 44 (12.9) 38 (13.5) 0.91
Connective tissue disease, n (%) 13 (2.1) 6 (1.8) 7 (2.5) 0.58
SOFA score 4 (2–7) 4 (2–7) 4 (2–6) 0.38
Invasive procedure
Central line catheter insertion, n (%) 273 (44.0) 155 (45.3) 118 (41.8) 0.42
Intubation, n (%) 167 (26.9) 98 (28.7) 69 (24.5) 0.28
CRRTx.,n (%) 38 (6.1) 22 (6.4) 16 (5.7) 0.74
Operation history, n (%) 92 (14.8) 51 (15.0) 41 (14.6) 1.00
Median duration of antibiotics treatment 6 (0–15) 7 (0–15) 6 (0–16) 0.59
Vancomycin use, n (%) 70 (11.3) 36 (10.6) 34 (12.1) 0.61
MRSA acquisition prior to ICU admission 57 (9.2) 36 (10.5) 21 (7.5) 0.21
ICU bed occupancy, % 82.0 83.7 81.5 0.22
Hand hygiene compliance of all HCW 72.1 71.6 72.7 0.62
Hand hygiene compliance of physicians 54.2 53.8 54.6 0.48
Hand hygiene compliance of nurses 89.9 89.4 90.5 0.64
Data are expressed as the mea / median (Q1-Q3) or N (%)
Abbreviation: NA not applicable, ICU intensive care unit, SOFA sequential organ failure assessment, CRRTx., continuous renal replacement therapy, HCW health
care workers
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methods such as hydrogen peroxide, ultraviolet light, and
copper-coated surfaces that proved effective in controlling
MRSA [15, 37, 38], photocatalysts still have the advantage
of easy application and durability. However, there is con-
cern that the effect is less prominent in stringently cleaned
settings. A study from the Netherlands conducted in an
ICU, where strict cleaning is a priority, found no micro-
biological benefit of photocatalyst [27]. However, that
study was conducted over a short period and further study
is needed to verify its efficacy in low-incidence settings.
We found no beneficial effect of photocatalyst on
MRAB. The photocatalysts we used lacked well-established
data of its antibiotic efficacy on MRAB. Although visible
light-activated composite TiO2 is generally expected to
have enhanced antimicrobial activity compared to pure
TiO2, only a limited number of organisms had been tested
in laboratory settings. Most of the studies used E.coli as
representative of gram-negative organism, and S.auerus as
representative of gram-positive organism [39]. It is not reli-
able to conclude that these materials are capable of inacti-
vating various kinds of microorganism beyond the scope of
organisms tested in laboratory settings. MRAB has differ-
ent structural properties in terms of outer membrane and
number of porins, compared to E.coli [40]. Since affinity of
ROS to outer membrane determines its antibacterial prop-
erty, different organisms can have different sensitivity to
photocatalyst [41]. Although we did not conduct active
surveillance and only counted incidental isolates of MRAB,
this questionable characteristic can partly explain why
MRAB incidence did not decrease. Notwithstanding, we
admit that the number of cultured MRAB was small. Fur-
ther study using larger number of patients for longer
period of time is warranted.
We did not observe any trend on clinical endpoints of
VRE due to low rate of these endpoints. Our study was
Fig. 1 Methicillin-resistant Staphylococcus aureus acquisition rate during the baseline and intervention periods, and compliance of hand hygiene
Fig. 2 Kaplan–Meier estimates of time to methicillin-resistant
Staphylococcus aureus acquisition. The cumulative probability of
methicillin-resistant S. aureus acquisition is shown for patients in the
baseline vs. intervention period. The relative hazard of acquiring
methicillin-resistant S. aureus in the intervention vs. baseline period
was 0.37(95% confidence interval, 0.14–0.99; p = 0.04).
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underpowered to detect clinically significant differences
in these endpoints because average length of ICU stay of
our study population was relatively short.
Reduced incidence of hospital-acquired pneumonia was
noted, while BSI and UTI were not significantly reduced.
Slightly higher percentage of cases of pneumonia was
caused by MRSA than by other infections. Only two cases
of BSI were caused by MRSA, while 5/29 cases of
culture-proven pneumonia were thought to be related to
MRSA. We cautiously concluded that reduced MRSA ac-
quisition partly explained decreased incidence of
hospital-acquired pneumonia. Additionally, considering
more than 50% of isolated organisms were gram-negative
bacteria, undetected benefits of photocatalyst may have
led to positive result. However, this hypothesis is not ro-
bust due to the lack of data supporting it, and study period
was relatively short for reduced colonization translated
into reduced infection. Moreover, incidence of pneumonia
could have been affected by various unquantifiable factors,
such as skill level of medical personnel.
It is most likely that reduced MRSA acquisition resulted
from reduced burden of MRSA on the environmental sur-
faces. However, our environmental culture surveillance
failed to support the hypothesis. No MRSA was isolated
on the surface culture. We did not use dipslide, which was
a highly recommend tool to collect MRSA from the envir-
onment, because this equipment was not widely available
in Korea. This could have underestimated the burden of
MRSA in the ICU environment. Nonetheless, significant
decrease of coagulase-negative Staphylococcus spp. on
environmental surfaces can be considered as surrogate
marker of environmental decontamination.
We acknowledge several limitations in our study. First,
general deep cleaning which was conducted generally at
the end of the year could act as confounding. We cannot
exclude that previous deep cleaning reduce MRSA acqui-
sition, and photocatalyst coating may serve as a mean to
maintain low level of environmental contamination. Sec-
ond, active surveillance was conducted only during ICU
stay, underestimating incidence rate of MRSA from pa-
tients who were discharged ICU within 48 h. Third, inci-
dence rate of organisms on which active surveillance had
not been conducted could have been under- or overesti-
mated. Finally, efforts to enhance hand hygiene and fol-
lowing effect of this strategy had not been performed.
Further study comparing the efficacy of photocatalyst
coating with that of enhanced hand hygiene is warranted.
Conclusions
In conclusion, this study is the first prospective cohort
study to evaluate the efficacy of photocatalyst in a prac-
tical setting and to provide evidence that photocatalyst
disinfection can be an adjunctive measure to control
MRSA acquisition in high-incidence settings.
Additional file
Additional file 1: Table S1. Number of positive isolates of environmental
culture according to identified organism and surfaces. (DOCX 19 kb)
Table 2 Comparison of MDRO acquisition rate and hospital acquired infection rates by study period
Variable Baseline Intervention IRR 95% CI p-value HRa 95% CI p-value
MRSA acquisition, n (%) 15 (4.4) 4 (1.4) 0.01
MRSA acquisition rate per 1000 patient-days 9.30 2.57 0.26 0.06–0.81 0.37 0.14–0.99 0.04
VRE acquisition, n (%) 1 (0.9) 2 (1.1) 0.54
VRE acquisition rate per 1000 patient-days 0.62 1.28 2.07 0.19–22.84
MRAB acquisition, n (%) 5 (6.4) 5 (8.5) 0.76
MRAB acquisition rate per 1000 patient-days 3.09 3.20 1.03 0.30–3.57
Blood stream infection, n (%) 6 (1.8) 10 (3.5) 0.28
Blood stream infection rate per 1000 patient-days 3.71 6.41 1.72 0.63–4.75
Pneumonia, n (%) 26 (7.6) 12 (3.2) 0.03
Pneumonia rate per 1000 patient-days 16.12 7.70 0.48 0.24–0.95 0.47 0.23–0.94 0.03
Urinary tract infection, n (%) 9 (2.6) 5 (1.8) 0.32
Urinary tract infection rate per 1000 patient-days 5.58 3.21 0.57 0.19–1.71
CDAD, n (%) 2 (0.6) 1 (0.4) 0.58
CDAD rate per 1000 patient-days 1.23 0.64 0.52 0.05–5.70
The incidence rate ratio was obtained by dividing the incidence rate in intervention period by the incidence rate in baseline period
Results having stastical significance was presented in boldface
Abbreviation: IRR incidence rate ratio, CI confidence interval, HR hazard ratio, MRSA methicilline resistant S.aureus, VRE vancomycin resistant Enterococcus spp.,
MRAB multidrug resistant A.baumannii, CDAD Clostridium difficile associated diarrhea
aHazard ratio was calculated using a multivariate Cox proportional hazards model, adjusted for length of ICU stay, SOFA score and having or not chronic renal diseases
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Abbreviations
BSI: Bloodstream infection; CDAD: Clostridium-difficile–associated disease;
CIs: Confidence intervals; HAI: Hospital-acquired infection; ICU: Intensive care
unit; MDROs: Multidrug-resistant organisms; MRAB: Multidrug-resistant
Acinetobacter baumannii; MRSA: Methicillin-resistant Staphylococcus aureus;
ROS: Reactive oxygen species; TiO2: Titanium dioxide; UTI: Urinary tract
infection; UV: Ultraviolet; VRE: Vancomycin-resistant Enterococcus spp
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